BioScience Health Innovations, Inc. (BHIC)

BHIC Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	5.69	1.84	0.6	0.07	-
Revenue Growth (YoY)	208.34%	208.73%	761.80%	-	-
Cost of Revenue	2.45	0.54	0.11	0.01	-
Gross Profit	3.24	1.31	0.48	0.06	-
Selling, General & Admin	2.52	1.22	0.74	0.17	0.01
Operating Expenses	2.52	1.22	0.74	0.17	0.01
Operating Income	0.72	0.09	-0.25	-0.11	-0.01
Other Non Operating Income (Expenses)	-	-	-	-0.06	-
Pretax Income	0.72	0.09	-0.25	-0.17	-0.01
Income Tax Expense	0.08	-	-	-	-
Net Income	0.64	0.09	-0.25	-0.17	-0.01
Net Income to Common	0.64	0.09	-0.25	-0.17	-0.01
Net Income Growth	638.03%	-	-	-	-
Shares Outstanding (Basic)	11	10	8	2	1
Shares Outstanding (Diluted)	11	11	8	2	1
Shares Change (YoY)	7.66%	25.44%	301.99%	147.38%	-
EPS (Basic)	0.06	0.01	-0.03	-0.08	-0.01
EPS (Diluted)	0.06	0.01	-0.04	-0.08	-0.01
EPS Growth	611.82%	-	-	-	-
Gross Margin	56.97%	70.94%	81.06%	86.01%	-
Operating Margin	12.64%	4.72%	-42.09%	-161.99%	-
Profit Margin	11.29%	4.72%	-42.09%	-245.81%	-
EBIT	0.72	0.09	-0.25	-0.11	-0.01
EBIT Margin	12.64%	4.72%	-42.09%	-161.99%	-
Effective Tax Rate	10.70%	-	-	-	-
Advertising Expenses	-	0.13	0.11	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.